(Q43950470)

English

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Laura Biganzoli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

A Awada

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T Cufer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

L Beex

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Lohrisch

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

V Batter

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A Hamilton

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Nooij

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Piccart

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

773-778

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced breast cancer: a phase II trial with gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine in combination with doxorubicin in advanced breast cancer: final results of a phase II pharmacokinetic trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of metastatic breast cancer with continuous infusional 5 fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900427-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(01)00427-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11937310%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43950470&oldid=2104596040"